Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Vaibhav Global Limited

Outcome of Board Meeting

Vaibhav Global Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a profit of Rs. 5,638.26 lakhs and a total comprehensive income of Rs. 5,593.88 lakhs. The company has also declared an interim dividend of Rs. 1.50 per equity share, with a record date of August 12, 2026.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Avalon Technologies Limited

Outcome of Board Meeting

Avalon Technologies Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026, with a revenue from operations of ₹2,106.40 crore and a profit before tax of ₹266.28 crore.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

R Systems International Limited

Outcome of Board Meeting

R Systems International Limited has announced its financial results for the quarter and six months ended June 30, 2026, with the company's income at ₹6,030.69 and expenses at ₹5,225.62, resulting in a profit of ₹805.07. The company has also approved the appointment of four new directors and the payment of remuneration to non-executive independent directors.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Sanofi India Limited

Outcome of Board Meeting

Sanofi India Limited has announced its financial results for the quarter ended June 30, 2026, with domestic net sales growth of 8% and total net sales growth of 6% compared to the second quarter of 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, and profits before tax and exceptional items increased 19% to INR 112 crores.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults4 Aug 2026

Sanofi India Ltd

Kindly refer the attachment

Sanofi India Ltd has announced its Q2 2026 financial results, reporting 8% domestic net sales growth and 6% total net sales growth compared to Q2 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27%.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

PTC India Limited

Outcome of Board Meeting

PTC India Limited has announced its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditors. The company's board of directors has approved and taken on record the financial results, which include an interim dividend of 230% (Rs. 23 per equity share) for the financial year 2026-27. The record date for the interim dividend has been fixed as August 10, 2026.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Uniparts India Limited

Outcome of Board Meeting

Uniparts India Limited has submitted its financial results for the quarter ended June 30, 2026, along with an independent auditor's limited review report. The company has declared a first interim dividend of Rs. 9.00 per equity share, with a record date of August 12, 2026.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Sundram Fasteners Limited

Outcome of Board Meeting

Sundram Fasteners Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a total income of Rs. 1,618.41 crore and a net profit of Rs. 150.97 crore.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults4 Aug 2026

Master Trust Ltd

OUTCOME OF BOARD MEETING OF THE MASTER TRUST LIMITED HELD ON 04.08.2026

Master Trust Ltd has announced its un-audited financial results for the quarter ended 30 June, 2026, showing a profit before tax of ₹198.0 crore, a 46.5% increase from the same quarter last year. The company's total comprehensive income for the quarter was ₹1,086.9 crore, with earnings per equity share of ₹1.0 for continuing operations and ₹0.3 for discontinued operations.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults4 Aug 2026

Bharti Hexacom Ltd

Outcome of Board Meeting for approval of Financial Results for the first Quarter (Q1) ended June 30, 2026

Bharti Hexacom Ltd has announced its audited financial results for the first quarter ended June 30, 2026, with revenue from operations at ₹25,099 million, a 10.4% increase from the previous year. The company reported a profit before tax of ₹6,530 million, a 23.5% increase from the previous year. The earnings per share (EPS) for the quarter stood at ₹9.65.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults4 Aug 2026

Regis Industries Ltd

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....

Regis Industries Ltd announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a net profit of Rs. 197.68 lakhs and an EPS of Rs. 0.08. The company's revenue from operations was Rs. 583.23 lakhs, with a cost of materials consumed of Rs. 375.69 lakhs. The board of directors approved the financial results at their meeting held on August 4, 2026.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults4 Aug 2026

Graphite India Ltd

Unaudited financial results for the quarter ended 30/06/2026

Graphite India Ltd has announced unaudited financial results for the quarter ended 30th June, 2026. The company reported a profit of ₹157 crore, with earnings per share (EPS) at ₹8.02. Revenue from operations was ₹765 crore, and total expenses were ₹674 crore. The company's segment revenue was ₹765 crore, with Graphite and Carbon segment contributing ₹651 crore. The company's total assets were ₹7,228 crore, and total liabilities were ₹1,437 crore.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Alembic Pharmaceuticals Limited

Outcome of Board Meeting

Alembic Pharmaceuticals Limited has submitted its financial results for the quarter ended June 30, 2026, with the Board of Directors approving the consolidated and standalone unaudited financial results along with the Limited Review Report issued by the Statutory Auditors.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Wonderla Holidays Limited

Outcome of Board Meeting

Wonderla Holidays Limited has submitted its financial results for the quarter ended June 30, 2026, with a profit before tax of Rs. 9,346.54 lakhs and a total revenue of Rs. 25,210.21 lakhs. The company has also allotted 15,105 shares to employees and granted 8,980 stock options to two employees.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026

Dr. Agarwal's Health Care Limited

Outcome of Board Meeting

Dr. Agarwal's Health Care Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, total income growing by 23.9% YoY to ₹620 Crores, IND-AS EBITDA growing by 25.2% YoY to ₹177 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults4 Aug 2026

Dr. Agarwals Health Care Ltd

Outcome of the Meeting of the Board of Directors of the Company held on August 04, 2026, is attached.

Dr. Agarwal's Health Care Ltd has announced its unaudited consolidated financial results for Q1 FY2027, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores. The company has also announced the appointment of new auditors, internal auditors, and cost auditors, and the incorporation of a wholly owned subsidiary in Nigeria.

Read more →📎 1 attachment